We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Federal Trade Commission Oversight of the Pharmaceutical Industry.
- Authors
Kapczynski, JD, Amy
- Abstract
An editorial focuses on the impact of high drug prices in the U.S., driven by monopoly dynamics facilitated through patents and other exclusive marketing rights held by pharmaceutical companies. It explores strategies such as patent thickets and pay-for-delay agreements that contribute to maintaining market control and generating substantial profits. The role of the Federal Trade Commission (FTC) in addressing these practices, are discussed.
- Subjects
UNITED States. Federal Trade Commission. Bureau of Consumer Protection; PHARMACEUTICAL industry; DISCLOSURE laws; PHARMACY benefit management; LEGAL education; NEOCLASSICAL school of economics
- Publication
JAMA: Journal of the American Medical Association, 2024, Vol 331, Issue 23, p1995
- ISSN
0098-7484
- Publication type
Opinion
- DOI
10.1001/jama.2024.1509